Hope Clinical Research | Canoga Park, California
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or without Type 2 Diabetes (T2D). The study will last around 31 weeks.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Have a body mass index (BMI) ≥27 kilogram/square meter (kg/m²)
Have either
Have been diagnosed with chronic kidney disease (CKD).
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
120 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal